These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22069258)

  • 1. Insulin as a key autoantigen in the development of type 1 diabetes.
    Nakayama M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):773-7. PubMed ID: 22069258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin--a primary autoantigen in type 1 diabetes?
    Wong FS
    Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.
    Li SW; Koya V; Li Y; Donelan W; Lin P; Reeves WH; Yang LJ
    Lab Invest; 2010 Jan; 90(1):31-9. PubMed ID: 19901909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin as an autoantigen in NOD/human diabetes.
    Zhang L; Nakayama M; Eisenbarth GS
    Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
    Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
    J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.
    Harrison LC
    Mol Metab; 2021 Oct; 52():101288. PubMed ID: 34242821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleting islet autoimmunity.
    Liu E; Li M; Jasinski J; Kobayashi M; Gianani R; Nakayama M; Eisenbarth GS
    Cell Biochem Biophys; 2007; 48(2-3):177-82. PubMed ID: 17709887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes induction in humanized mice.
    Tan S; Li Y; Xia J; Jin CH; Hu Z; Duinkerken G; Li Y; Khosravi Maharlooei M; Chavez E; Nauman G; Danzl N; Nakayama M; Roep BO; Sykes M; Yang YG
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10954-10959. PubMed ID: 28874533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
    Dotta F; Dionisi S; Viglietta V; Tiberti C; Matteoli MC; Cervoni M; Bizzarri C; Marietti G; Testi M; Multari G; Lucentini L; Di Mario U
    Eur J Endocrinol; 1999 Sep; 141(3):272-8. PubMed ID: 10474125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
    Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
    J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A is an autoantigen in type 1 diabetes.
    Stadinski BD; Delong T; Reisdorph N; Reisdorph R; Powell RL; Armstrong M; Piganelli JD; Barbour G; Bradley B; Crawford F; Marrack P; Mahata SK; Kappler JW; Haskins K
    Nat Immunol; 2010 Mar; 11(3):225-31. PubMed ID: 20139986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.
    Tian J; Dang H; von Boehmer H; Jaeckel E; Kaufman DL
    Diabetes; 2009 Dec; 58(12):2843-50. PubMed ID: 19741165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
    Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS
    Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice.
    Martinic MM; Juedes AE; Bresson D; Homann D; Skak K; Huber C; Ling E; Ejrnaes M; Wolfe T; Togher L; Christen U; von Herrath MG
    Diabetes; 2007 Apr; 56(4):1059-68. PubMed ID: 17395746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIPs and HIP-reactive T cells.
    Wiles TA; Delong T
    Clin Exp Immunol; 2019 Dec; 198(3):306-313. PubMed ID: 31132145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.